Left Ventricular Dysfunction clinical trials at UCSD

• Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function

  Sorry, not yet accepting patients

  The purpose of this study is to assess if using the Impella® CP (or Impella® 2.5) device during high-risk PCI in patients with reduced left-sided heart function will result in an improvement in symptoms, heart function and health after a heart procedure compared to the current standard of care.

  San Diego, California and other locations

Last updated: March 16, 2021